FindTrial
Sign In

Correlation of dermatoscopic features of vitiligo with the disease activity and response to treatment

A study to sequentially determine the dermatoscopic features of vitiligo and its correlation with disease activity and treatment response

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/06/025516
Enrollment
30
Registered
2020-06-01
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L80- Vitiligo

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: Nil

Sponsors

Department of Dermatology
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients with clinical diagnosis of segmental or non segmental vitiligo 2. Patients with active disease 3. Patients initiated on medical management

Exclusion criteria

Exclusion criteria: 1. Patients with stable disease 2. Patients who receive phototherapy or surgical management 3. Patients who did not give consent for participation in the study

Design outcomes

Primary

MeasureTime frame
To sequentially determine the dermatoscopic features of vitiligoTimepoint: Baseline, 4 weeks, 8 weeks, 12 weeks, 16 weeks, 20 weeks, 24 weeks—

Secondary

MeasureTime frame
1. To correlate dermatoscopic features with disease activity assessed by means of VIDA and VASI 2. To correlate dermatoscopic features of repigmentation with treatment modality usedTimepoint: 24 weeks—

Countries

India

Contacts

Public ContactVinay K

Department of Dermatology, PGIMER, Chandigarh

Vinay.keshavmurthy@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026